Can D-dimer be Used as a Marker for Thromboembolic Events in Pediatric Patients With COVID-19?
- 29 February 2024
- journal article
- research article
- Published by Sociedade Brasileira de Cardiologia in International Journal of Cardiovascular Sciences
- Vol. 37
Abstract
D-dimer is a protein resulting from fibrin degradation. It is released into the circulation when clot degradation occurs and is therefore used as a marker for thromboembolic events and fibrinolysis. The main role of D-dimer lies in its negative predictive value for the exclusion of thromboembolic events, when its level is below 500 ng/mL. Because D-dimer functions as an inflammatory marker, various non-thromboembolic situations can contribute to an increase in its level, such as advanced age, pregnancy, postpartum period, neoplasms,Keywords
This publication has 12 references indexed in Scilit:
- Standardization of D‐dimer reporting in the COVID‐19 eraResearch and Practice in Thrombosis and Haemostasis, 2022
- Thromboprophylaxis for children hospitalized with COVID‐19 and MIS‐CResearch and Practice in Thrombosis and Haemostasis, 2022
- COVID-19 Management in the Pediatric Age: Consensus Document of the COVID-19 Working Group in Paediatrics of the Emilia-Romagna Region (RE-CO-Ped), ItalyInternational Journal of Environmental Research and Public Health, 2021
- The inflammatory markers of multisystem inflammatory syndrome in children (MIS‐C) and adolescents associated with COVID‐19: A meta‐analysisJournal of Medical Virology, 2021
- Diagnostic Value of D-Dimer in COVID-19: A Meta-Analysis and Meta-RegressionClinical and Applied Thrombosis/Hemostasis, 2021
- Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromesThe Lancet Respiratory Medicine, 2020
- Guidance on diagnosis, prevention and treatment of thromboembolic complications in COVID-19: a position paper of the Brazilian Society of Thrombosis and Hemostasis and the Thrombosis and Hemostasis Committee of the Brazilian Association of Hematology, Hemotherapy and Cellular TherapyHematology, Transfusion and Cell Therapy, 2020
- Thrombosis risk associated with COVID-19 infection. A scoping reviewThrombosis Research, 2020
- Reporting of D-dimer data in COVID-19: some confusion and potential for misinformationClinical Chemistry and Laboratory Medicine (CCLM), 2020
- Venous thromboembolism in childhood: A prospective two-year registry in The NetherlandsThe Journal of Pediatrics, 2001